Peak Bio, Inc.
PKBODelisted Mar 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001834645
Peak Bio, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Dec 4, 2024; 9 institutions reported holding it in 13F filings for Q4 2022, worth $2.53M in total; no superinvestor held it.
Holders of 5% or more of PKBO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Peak Bio, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Peak Bio, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
16 Schedule 13D and 13G filings on Peak Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 4, 2024 | Sbi Investment Korea Co., Ltd. | 13G/AOld format | – | – | – | SEC |
| Mar 21, 2023 | Huh Hoyoung | 13DOld format | – | New | – | SEC |
| Feb 28, 2023 | Sbi Investment Korea Co., Ltd. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Vellar Opportunities Fund Master, Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2023 | Frost Phillip MD Et Al | 13G/AOld format | – | – | – | SEC |
| Aug 31, 2022 | Vellar Opportunities Fund Master, Ltd. | 13GOld format | – | New | – | SEC |
| May 9, 2022 | Oliveira Steven Michael | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Saba Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Jan 26, 2022 | K2 Principal Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 5, 2022 | K2 Principal Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Jul 15, 2021 | K2 Principal Fund, L.P. | 13GOld format | – | New | – | SEC |
| Feb 25, 2021 | Frost Phillip MD Et Al | 13GOld format | – | New | – | SEC |
| Feb 3, 2021 | Flynn James E | 13GOld format | – | New | – | SEC |
| Feb 2, 2021 | Oliveira Steven Michael | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Peak Bio, Inc. shares.
No Form 144 notices for Peak Bio, Inc. are on file.